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Abstract
The concept of frailty as a health dimension in old age is recent and has its
origin in the development of geriatric medicine. Initially an unformulated clinical
intuition, it is now defined by a diminished physiological reserve of multiple
organs that exposes older individuals to increased vulnerability to stressors and a
higher risk of adverse outcomes.
The operational definition of frailty, however, is still debated. From a diversity of
models, two emerged in the early 2000s from epidemiological studies
conducted in large population-based aging cohorts. The body of research
emphasized prospective associations between a frailty phenotype and a range of
adverse outcomes or between a frailty index measuring the accumulation of
deficits and death. A few studies showed promising spontaneous remissions in
the early stages of frailty, raising expectations for effective interventions.
Transitions between frailty stages and effective interventions on frailty
nevertheless remain two fields needing further investigation.
More recently, these tools have been applied as screening instruments in clinical
settings to guide individual decision-making and orient treatments. New
questions are raised by the use of instruments developed to screen frailty in
epidemiological research for assessing individual situations. Inquiring whether
frailty screening is relevant opens a Pandora’s box of doubts and debates.
There are many reasons to screen for frailty both from a public health and a
clinical perspective that are only exacerbated by the current demographic
evolution. Open questions remain about the feasibility of frailty screening, the
properties of screening tools, the relevance of an integration of socioeconomic
dimensions into screening tools, and the effectiveness of interventions targeting
frailty. Fifteen years after the publication of the Fried and Rockwood landmark
papers proposing operational definitions of frailty, this article presents an
overview of current perspectives and issues around frailty screening in
populations and in individuals.
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Introduction
In just 15 years, the concept of frailty in old age has significantly grown in importance,
as evidenced by numerous research publications and its inclusion in most geronto-
logical conference programs. Two current features of demographic aging explain our
sustained interest in frailty despite a persistent lack of consensus about its operational
definition and our limited knowledge about its causes.
First, increasing longevity gives chronic diseases the time to manifest, develop, and
evolve, leading to consequences such as frailty and functional decline. Although cente-
narians were exceptional a few decades ago, they no longer are today. The burden of
disability from advanced age is now highly visible and expected to increase with
continuing progress in life expectancy. The fast growth in numbers in the oldest age
category not only creates a need to develop long-term care services but also has a
strong impact on all healthcare settings. Older patients represent a major share of
primary care physician consultations, emergency room visits, and acute hospital admis-
sions. Although disability is frequent in old age, health state is heterogeneous, and
many older individuals are robust. As surgical procedures and invasive medical treat-
ments are increasingly performed on geriatric patients, physicians are often confronted
by the need to evaluate the frailty of an older patient.
Second, past demographic events, such as the post-World War II baby boom, will
influence our near future. A large generation is currently reaching its third (active
retirement) age, with the prospect of a high residual life expectancy. Chronic diseases
are already present in this population at a clinical, and possibly subclinical, stage with a
high prevalence. The second quarter of this century will witness the fourth (dependent)
age of this numerically consequent cohort, with high risk of an epidemic of age-related
disability and resulting pressure on healthcare systems as a whole. The coming years offer
a window of opportunity for interventions to reduce the impact of this demographic event
of the past on the health of aging populations, with frailty as a central target.
Although demographic circumstances justify investments in frailty research, the many
unknowns around it raise questions about the pertinence and feasibility of screening
for frailty in old age, from both public health and clinical perspectives. Basic conditions
for screening are that we know what we are screening for (i.e., frailty can be defined);
that without screening the characteristic we screen for would remain unobserved; that
we have adequate instruments of detection that are sensitive, specific, and predictive;
and that screening results can prompt effective intervention or management decisions.
This article reviews the developments of research on frailty in older populations and
individuals since the turn of this century speaking for or against screening for frailty in
a context of scarce knowledge and urgency.
Frailty at the turn of the twenty-first century
Do we know what we want to screen for?
The concept of frailty is recent, as is geriatric medicine: it emerged during the last
quarter of the twentieth century. The gap between chronological and biologic age of
older individuals—and the need to consider the second rather than the first to treat
older patients appropriately—is at the heart of clinical practice in geriatrics. Although
one or more chronic conditions are in most cases present in older patients, at any given
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age, their number, combinations, severity, and impact on functional capacities are very
diverse, so that although the prevalence of chronic diseases is highest in older age, the
chronologic age of an individual does not necessarily equate with the risk of disability
and death. The frailty of an older person is often expressed as a level of intrinsic vul-
nerability. It tends to increase with chronological age but it is not confounded with it.
Likewise, frailty may be the precursor of a progressive dependency in activities of
daily living (ADL); therefore, many dependent older individuals are both frail and
disabled. However, all disability in old age does not result from frailty, and all frail indi-
viduals are not necessarily functionally dependent. After some debate, frailty is now
considered to be a distinct health dimension, aside from comorbidity and functional
dependency, and as a pre-disability stage [1].
Although the definition of frailty is still under dispute, there is some consensus
around considering it a health condition “with multiple causes and contributors that is
characterized by diminished strength, endurance, and reduced physiologic function that
increases an individual’s vulnerability for developing increased dependency and/or
death” [2]. Whether or not frailty may exist in the absence of multiple chronic condi-
tions and functional loss is nevertheless not yet established. First, chronic diseases may
be present but still at a preclinical stage or undiagnosed in some frail individuals who
decline in their functional capacities without having met the threshold that delineates
the need for help [3]. Second, frailty might also exist in some cases in the total absence
of chronic conditions and functional decline. Frailty is a progressive health characteris-
tic with potentially preventable negative consequences. In principle, screening for frailty
is thus desirable, provided that we develop adequate instruments to identify it, particu-
larly before reaching a state of functional dependency, and know enough to act on it.
Frailty is here conceptualized as a dimension of health. Its definition, however, also
refers to vulnerability, another concept needing clarification. According to Chambers [4],
vulnerability is a broader concept than frailty. It includes both frailty (intrinsic health
characteristic) and exposure to shocks and stress that may be external. Therefore, vulner-
ability has additional, environmental components (including socioeconomic circum-
stances) which themselves are recognized determinants of health (including, potentially,
of frailty). Frail individuals are vulnerable; environmental factors are both likely to increase
their level of frailty and to have an independent effect on their level of vulnerability.
Do we know how to detect and measure frailty?
Many models, definitions, and instruments were proposed at the turn of this century
to operationalize the definition of frailty and identify frail individuals [5, 6]. Two
approaches emerged from prospective, quantitative research conducted on large
samples of community-dwelling populations, both described in landmark papers pub-
lished in 2001. The frailty phenotype defined by Fried et al. [7] refers to the multisys-
tem loss of physiological reserve that delineates frailty as a risk for a range of adverse
outcomes. Fried’s frailty phenotype relies on a biological conceptual model in which
frailty has close links with sarcopenia, neuroendocrine decline, and immune dysfunc-
tion [8, 9]. It is based on the observation of five characteristics (shrinking, weakness,
slowness, exhaustion, and low activity), each measured by one single criterion derived
from a secondary analysis of data from the Cardiovascular Health Study (CHS).
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Shrinking is defined by weight loss, weakness by low grip strength measured with a dyna-
mometer, slowness by low walking speed, exhaustion by self-reported fatigue based on
two items from a questionnaire designed to assess depressive symptoms, and low activity
from an estimate of energy expenditure based on a leisure-time activity questionnaire. All
criteria are considered equally to classify individuals as frail (3 to 5 criteria), intermediate
or pre-frail (1 or 2 criteria), or not frail (none). The large diffusion of Fried’s frailty pheno-
type may be due to its face validity and at least partly to the limited number of variables
that need to be measured. It has nevertheless been criticized for reducing frailty to the
physical aspects of health, thus neglecting mental health problems that are frequent in old
age such as mood disorders or cognitive limitations that may contribute to frailty [3].
However, the five indicators proposed by Fried et al. are likely to reflect mental health as
well: weight loss, fatigue and low physical activity are observed in depression and demen-
tia; fatigue is measured by items from a depression screening tool; and recent research
has pointed to the relationships between frailty and cognitive limitations [10, 11]. Further-
more, multiple correspondence analyses performed in several populations on the five
phenotype dimensions with depression and cognition suggested that all belong to a
common construct [12].
The “accumulation of deficits” model, described by Mitnitski and Rockwood, relies
on a frailty index computed from a large number of health variables [13]. It refers to
the concept of advanced biological age related to the risk for dying. This model was
developed based on data from the Canadian Study of Health and Aging, making use of
more than 90 individual variables such as medical diagnoses, self-reported health prob-
lems or symptoms, signs, results of laboratory tests, or functional difficulties in ADLs.
Each variable contributes equally to the frailty index, which is defined as their arith-
metic sum. Three principles guide the selection of variables: they indicate health prob-
lems of increasing prevalence with age, they point to more than one system, and they
do not reflect conditions that are universally present in old age (and would thus not
discriminate between individuals of the same chronological age). In theory, the set of
variables selected to compute the index of frailty may change between different samples
as long as the number of variables included is large, at least 30 to 40 [14]. The “accumula-
tion of deficits” model does not provide clues to the underlying physiological mechanisms
leading to frailty. However, the large range of health deficits measured to compute the
frailty index takes into account the multidimensionality of frailty, including its physical
and mental aspects. The frailty index has two other valuable characteristics: it can be
computed from any database that provides a large set of health indicators, and it measures
frailty on a continuous scale.
The frailty phenotype and the frailty index thus coexist as complementary tools [15]
to detect frailty in large samples of the population. In a recent comparison of the two
instruments, the frailty index identified a much higher proportion of the community-
dwelling population as frail [16]. Other instruments, such as the Tilburg Frailty Indica-
tor or the Groningen frailty indicator, are designed to capture frailty in old age as a
more global concept and include psychosocial characteristics [17, 18]. By including
psychosocial factors, these instruments tend towards the broader concept of vulnerabil-
ity. When applied in the same population, they classify as frail an even larger propor-
tion than the frailty index and, unfortunately, the currently available instruments
designed to detect frailty poorly agree with each other [19].
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All instruments used today to identify frailty were essentially validated through
demonstration of their prospective association with adverse outcomes in population-
based cohort studies. In general, the frailty index is more predictive of death than the
frailty phenotype [16, 19]. However, its definition includes indicators of disability; as a
consequence, it cannot be used to predict the incidence of functional decline. The
frailty phenotype, in its original definition or in versions adapted to available data, has
been found to be independently associated with the incidence and worsening of func-
tional decline in several cohorts [7, 20–22]. Frailty may not only progress towards more
severe stages [23] and lead to disability but it may also regress spontaneously, particu-
larly early in its course, as shown in studies with measurements based either on the
frailty phenotype [24–26] or on the frailty index. [27, 28] This natural history underlies
the hope that a better understanding of frailty and its determinants will result in the
design of effective interventions aiming at both a slower progression towards more
severe stages and at less unfavorable functional outcomes.
Frailty screening and public health in aging societies
Although the concept of frailty originated in the clinical concerns of geriatricians for
their patients, it was essentially developed through population-based epidemiologic
research and should have important applications for the practice of public health in
aging societies. Monitoring population health, planning for appropriate health services,
and identifying subgroups at higher risk for preventive actions to avoid adverse health
outcomes are basic activities that potentially could benefit from screening for frailty in
older general populations.
Frailty and monitoring of older populations’ health
Because chronic conditions and their consequences are related to old age, a degrad-
ation of the population health is expected in most countries, for structural reasons,
with the phenomenon of demographic aging. The extent to which younger cohorts,
who benefit from a higher life expectancy, are in better health when they reach retire-
ment age is unsure and appropriate indicators are needed to estimate the level of
health, particularly in the “young-old” age category. The evaluation of population-based
interventions and of changes in the organization of healthcare systems promoted under
the auspices of health and aging policies should also rely on health indicators that are
pertinent for all age subgroups of the older population.
The usual health indicators, like the frequency of specific diagnoses, are not appropri-
ate for comparing the health of older populations over time, between places, or among
subgroups of the population delineated by non-medical criteria. Socioeconomic charac-
teristics may influence care-seeking behaviors and the access to diagnostic procedures
for several reasons, including perceptual, cultural, and financial, leading to biased
comparisons of morbidity. Chronic conditions need to be diagnosed before being
reported, assuming that the individual did not postpone or forfeit healthcare some time
before the survey interview. Furthermore, specific diagnoses are only partly relevant to
describing health at an age of widespread comorbidity. Disability indicators, although
appropriate for measuring health in older populations, have limitations because they
are mostly relevant at the age of 80 and more. They are not so helpful in describing the
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health of older populations when a large proportion is in the third age, which will be
the dominant situation in the coming decade. Screening for frailty provides a comple-
mentary, diagnosis-independent, indicator of health relevant to the whole range of old
age and quantifying its vulnerability.
Frailty as an indicator of need for health services
Planning for healthcare resources is another public health task for which assessing
the level of frailty in the population may be useful. Both the frailty phenotype and
the frailty index are associated with the use of health care in the community [16, 29].
The frailty phenotype is also associated with admission to nursing homes [20], and
the Tilburg Frailty Indicator seems to be linked to the use of a wide range of health
services [30]. By contrast, in severely disabled older persons living in the community,
frailty was not associated with more frequent visits to emergency departments [31].
However, relationships between frailty and health services use in general community-
dwelling populations deserve more research because several hypotheses could explain
them. Frailty might result from treatments that imply multiple contacts with health
services either for prescription or for the treatment of secondary effects. It could also
be the consequence of inappropriate incentives for healthcare systems, like prema-
ture hospital discharge of frail patients in diagnosis-related group payment systems
or the neglect of secondary or tertiary prevention in time-rationed consultations,
resulting in health decompensation and the need for costly care. A perception of
frailty by older patients in the absence of detected disease or functional loss may also
lead to a feeling of unmet need and multiple demands on health services.
Frailty as a target of population-based interventions and public policies
The third reason to screen for frailty in older populations is the possibility of designing
and implementing preventive, population-based interventions targeting identified risk
factors. Achieving this aim will necessitate more investment both in epidemiological
research on the determinants of frailty and its consequences, with an emphasis on
modifiable risk factors for frailty incidence, worsening and evolution towards disability,
and in the evaluation of the effectiveness of interventions in various populations and
their subgroups. Although much effort has been invested in the definition and valid-
ation of screening instruments, we still know little about these two aspects besides
repeated observations of higher levels of frailty in women [7, 32] and in socioeconomi-
cally disadvantaged subgroups [33–36]. Therefore, frailty screening instruments used to
identify subgroups at risk should be limited to health dimensions and keep socioeco-
nomic characteristics apart, as potential explanatory risk factors for frailty on which
non-medical action could be taken. Socioeconomic circumstances also remain to be
investigated as independent components of vulnerability that may interact with frailty
as determinants of adverse health outcomes.
If early stages of frailty are the most appropriate target for intervention—because they
are more likely to be reversible—and if they correspond to preclinical (or undiagnosed)
chronic conditions and functional loss, a first modifiable factor is the capacity of
medical care to identify hidden problems. Healthcare systems were designed in the past
century mainly to respond to the acute care needs of a young population. Their initial
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response to population aging was an increase in nursing home supply. It was followed
by the development of home care and help services, supported by intermediate care
services such as respite care or sheltered housing and, more recently, by efforts to
coordinate the care provided by a growing diversity of services. It is unclear, however,
that this re-organization of health services succeeded in encouraging health profes-
sionals, through adequate financial incentives, to invest their time and resources in the
detection and systematic treatment of hidden chronic diseases, dental problems,
sensory deficits, functional losses, mood disorders, and cognitive impairments, all
factors that most probably signal the incidence of frailty and influence its course. Adap-
tations of health insurance and social security policies are primary targets to correct
these frequent and sometime neglected health problems in old age. Socioeconomically
disadvantaged populations may be particularly sensitive to this type of intervention.
The French experience of social policy agencies, currently screening retirees for frailty
to offer targeted reinforced care and support to vulnerable individuals, is an example of
a promising public policy intervention [37]. It would require a detailed evaluation to
demonstrate its effectiveness.
The observation of associations between social isolation and frailty points to another
potential for action. A low level of physical activity and reduced social contacts may be
improved when streets and post offices offer comfortable seats that permit older
persons with mobility limitations to engage in a walk outside their home. Programs to
promote friendly cities for the older population are an opportunity to test the effect of
this type of interventions on frailty in old age. Other interventions such as programs to
increase older persons’ computer and digital literacy may also help to keep them inte-
grated in social exchanges. Whether or not these interventions would prove effica-
cious in reducing the level of frailty in older populations is unknown. They should be
evaluated by appropriate monitoring of frailty indicators in population-based surveys.
Measurement tools to compare the level of frailty in populations
For purposes of epidemiologic comparisons, the frailty index suffers from its reliance
on medical diagnoses that reflect not only the population health but also the perform-
ance of healthcare systems, which is likely to vary over time, across regions and among
population subgroups. From this point of view, the frailty phenotype may be more
appropriate for comparing populations with differential access to care. Geographic vari-
ations of the frailty phenotype in older populations have been shown in the Survey of
Health, Aging and Retirement in Europe (SHARE) study [36]. However, two conditions
are necessary for epidemiological comparisons that contrast regions or population
subgroups using Fried’s phenotype as a screening tool: the operationalization of its five
dimensions must be identical in the compared populations, and thresholds for defining
low walking speed, grip strength, and physical activity must not be adapted to each
country. The cut-offs empirically determined in the CHS for these three dimensions by
Fried et al. were validated by associations of the frailty phenotype with adverse health
outcomes, including death and disability [7]. They can be used in populations of similar
structure. Remaining bias in population comparisons may nevertheless result from the
self-assessment of fatigue as a measure of exhaustion in Fried’s phenotype. The effect
of a country-specific response style on the assessment of subjective health has been
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demonstrated in the SHARE survey [38]. Another, more logistical concern is the neces-
sity of direct observation of performance tests to assess this phenotype, which results
in a sizable proportion of non-random missing data with a disproportionate mortality
observed in incompletely evaluated subjects [19]. The conduct of performance tests
also generates higher costs in large population surveys. Therefore, recent studies have
tried to identify more simple instruments to measure frailty in the community, using
the frailty phenotype, the frailty index, or a comprehensive geriatric assessment as a
reference. These studies are based exclusively on self-reported information collected in
postal questionnaires [39, 40], use shorter instruments [41], or limit the observation to
a single dimension [41, 42]. In this last case, a slow walking speed is found to be a
sensitive test for detecting frailty. Other studies evaluated the predictive capacity of
selected performance tests for mortality [43] or incidence of disability [44] in samples
of the community-dwelling population. For both outcomes, walking speed has been
identified as a useful risk indicator, one also highlighted in a review of physical frailty
indicators predicting difficulties in ADLs [45].
From the population to the individual
Whether patients should be screened for frailty in clinical settings is a more recent and
controversial question. Several recommendations issued by agencies or after consensus
conferences push for the application of frailty screening in patients [1, 2, 46, 47]. The
most evident reason is the potential for prevention suggested by a spontaneous revers-
ibility of frailty in non-disabled individuals in the early stages of frailty. This potential is
nevertheless challenged by the current lack of specific interventions of proven efficacy
and effectiveness for frail individuals [48].
Other motivations may justify the adoption of frailty screening in clinical settings.
They result from the availability of invasive medical and surgical treatments that can
benefit older patients even at an advanced age but can be deleterious in frail individ-
uals. Some of these treatments are expensive, per se or as a result of their complica-
tions in frail patients. Screening for frailty is considered appropriate for discussing the
risk of treatments with patients, guiding decisions between different care options, and
reinforcing perioperative care when invasive treatments are necessary [49]. It has also
been advocated to protect patients against age-based rationing of care as well as physi-
cians against accusations of ageism [50, 51].
Screening for frailty in primary care
A central question is the extent to which frailty screening instruments validated in
population-based studies and showing prospective associations with adverse outcomes
can accurately predict these outcomes at an individual level. Frailty screening instru-
ments used to decide treatments in clinical practice must be sensitive so as to detect
most patients needing special attention and specific so as to avoid denying effective
treatments to robust patients falsely classified as pre-frail or frail. Available instruments
tend to have high sensitivity but limited specificity. Frailty screening instruments must
also have good positive and negative predictive values, which, unlike sensitivity and
specificity, are influenced by the prevalence of frailty. In the community, the predictive
value of a set of the most common indicators of frailty was found to be very limited
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once age, sex, and chronic diseases were taken into account [52]. A review of the pre-
dictive accuracy of six instruments in diverse settings showed that, because of the low
frequency of poor health outcomes, their sensitivity and specificity led to insufficient
negative, and even more positive, predictive values [53]. In clinical practice, their
predictive value is expected to be lower in primary care than in settings visited by
severely diseased patients, such as oncology, or by functionally limited patients, such as
those in long-term care. As a consequence, their use by primary care physicians to
discuss treatment options with patients should be particularly cautious.
The use of primary care data to measure frailty is attractive, but a recent experience
suggested that the frailty index was only moderately able to predict poor outcomes
[54, 55]. Other instruments simultaneously applied in primary care showed limited
concordance in the detection of frail patients [56–58], and their validation and adjust-
ment to the circumstances of primary care require further research [59–61]. Among
the tools tested in primary care to detect frailty, some include socioeconomic dimen-
sions [56, 57, 60, 62]. This approach may be valuable when the purpose is to capture
frailty globally in order to reinforce supportive care when needed, including for socioeco-
nomic reasons. However, these instruments may be unethical when the social dimension
is predominant in an assessment of frailty used to decide whether a costly intervention is
appropriate because disadvantaged individuals will thus be denied care on the grounds of
their social vulnerability.
Screening for frailty in patients with selected conditions
Various frailty indicators are associated with adverse outcomes in patients with coron-
ary heart disease, such as the frailty index, which is strongly and independently related
to in-hospital and 1-month mortality in non-ST elevation myocardial infarction [63], or
the Edmonton frailty scale, which is associated with adjusted mortality and other out-
comes [64]. In patients of the cardiology ward with at least double-vessel coronary
artery disease, walking speed better predicted 6-month mortality than the frailty pheno-
type. In this case, the walking speed had similar positive predictive value and better
negative predictive value, but only slightly more than one in ten classified as frail by
these two methods saw this outcome [65].
In middle-aged patients with chronic kidney disease not undergoing dialysis, the frailty
phenotype prevalence was much higher than that in population-based controls. In
addition, Fried’s phenotype was associated with a higher risk of dialysis or death [66].
Airflow limitations and a pulmonary restrictive pattern were found to be cross-
sectionally associated with the frailty phenotype in the CHS. An increased risk of
developing frailty was observed when they were present at baseline and vice versa.
Mortality increased when frailty and respiratory conditions were both present [67].
In oncology, frailty screening has been investigated for its potential to target patients
needing referral to comprehensive geriatric assessment (CGA). A review of several
instruments suggested an insufficient discriminative power of frailty screening tools to
predict impairment. Instruments that had the highest sensitivity had a negative predict-
ive value too low to justify their use for selecting patients for CGA [68]. Others reached
the same conclusion [69, 70]. A pilot study suggested a prospective association between
grip strength and oncologic treatment toxicity but did not provide information on its
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predictive ability [71]. The same study failed to show a significant relationship between
frailty markers and visits to general practitioners or hospital admissions [72].
Screening for frailty in the hospital
The frailty index method is attractive for the evaluation of inpatients because a large
number of health variables are routinely collected at hospital admission. Several frailty
screening tools, including both the frailty index and the frailty phenotype, predicted
adverse outcomes at discharge from a geriatric unit and 6 months later, but only the
frailty index seemed to have an adequate discriminatory power at both times [73].
Fried’s frailty phenotype was also singled out as a significant risk factor for 6-month
adjusted mortality but was not associated with in-hospital falls and delirium [74]. In
another study, five different frailty scales were all associated with mortality, readmis-
sion, functional decline and a composite outcome but their predictive properties were
poor, leading the authors to conclude that frailty scales alone are insufficient to stratify
older patients discharged from acute medical units [75].
Associations with adverse outcomes and the accuracy of prediction of frailty indica-
tors were also investigated in specific hospital departments. In trauma patients and
emergency departments, the frailty index was strongly related to death and discharge
dispositions but not repeat visits to the emergency room [76, 77]. It may, however, be
difficult in this setting to measure physical performance to determine the level of
Fried’s frailty phenotype; self-assessed weakness and slowness in emergency room
patients have been found to be poorly sensitive for this indicator [78].
Screening for frailty in surgical patients
Most instruments designed to estimate perioperative risk focus on one single organ
whereas older patients accumulate multiple diseases. Frailty screening tools might help
anesthetists and surgeons to appreciate objectively the global health of their patients
[50, 79]. A frailty index was found to be associated with complications and the adjusted
mortality risk in emergency general surgery [80] and the frailty phenotype with the
complications, length of stay, and discharge dispositions in elective surgery, increasing
significantly the predictive power of three perioperative risk indexes [81, 82]. Conflict-
ing results were found in abdominal surgery: an approximation of frailty by routine
preoperative data predicted 30-day mortality, and to a lesser extent major morbidity,
after lower gastrointestinal surgery in one study [83] while the frailty index was not
associated with 30-day postoperative complications in another [84]. In elective non-
cardiac, mostly orthopedic surgery, the Edmonton frailty scale was associated with the
same outcomes independent of age [85]. Compared to the patients’ and surgeons’
appreciation of frailty, the measured frailty phenotype may correct for unrealistic
expectations from patients and an overreliance by clinicians on chronological age [86].
Recent reviews confirmed the relationships between frailty assessments and periopera-
tive outcomes regardless of surgical populations and tools. They also underlined the
heterogeneity of research methods and the need for further research to address which
assessment method is most predictive [87–89]. A similar conclusion was reached in
another review looking at the effectiveness of preoperative CGA on surgery outcomes,
despite results predominantly in favor of this type of evaluation [90].
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Cardiac surgery is probably the most investigated specialty in research on frailty
screening. Walking speed and a score of disability were found to be predictive of
mortality or major morbidity in bypass or valve surgery, and both frailty and disability
significantly improved the prediction from a cardiac surgery risk score [91]. The Fried
phenotype predicts death as well as death or myocardial infarction after percutaneous
revascularization [92]. Several reviews have pointed to frailty as an independent risk
factor for perioperative morbidity [93] and death [94] in cardiac surgery, with possibly
a better predictive ability in older than in younger patients [95]. Improvements in the
prediction seem to be modest [94]; thus, as Afilalo et al. emphasized, a positive frailty
assessment should not guide rationing decisions but rather designate patients needing
reinforced care [96].
Frailty as a target of individual preventive interventions
Following early calls to design randomized control trials for preventive interventions
targeting frailty [97], several projects aimed at building the evidence for action. Overall,
physical exercise, with or without nutrition supplements, is the most frequent compo-
nent of interventions targeting frail older persons [98], and it seems to be beneficial to
both physical performance and functional status although the most effective type of
exercise remains to be determined [99–102]. Interventions in the community or in pri-
mary care settings often share a three-step structure: frailty screening to identify pre-
frail or frail older persons, CGA to define individual needs, and a multidimensional
intervention to match these needs in the frame of individual care plans [103–115]. The
components of interventions include physical exercise, nutrition, lifestyles, cognitive
training, medication review, and specific clinical targets and evidence-based care plans
for geriatric conditions. Other studies have targeted patients after major abdominal
surgery [116], tested limited interventions such as exercise and nutrition [117–119], or
relied on nursing home visits [120] or on recommendations to primary care physicians
and health and social services [121]. Nevertheless, the evidence regarding the effective-
ness of individual interventions designed to prevent an evolution towards more severe
stages of frailty and their consequences remains weak because several trials are still in
the design or pilot phases.
Conclusion
Frailty remains a focus of recent research and requires additional investigation in all
aspects. Despite our limited knowledge, demographic circumstances raise urgent ques-
tions both for public health practitioners and clinicians, explaining the fast diffusion of
the frailty concept. Accordingly, several recent guidelines and consensus conferences
converged to recommend routine screening for frailty in older adults [2, 47, 122, 123].
Learning by doing will probably be the rule in the next decade. Frailty, as an integra-
tive indicator of health in the whole range of old age, is worth screening to monitor
population health. Its effect and inter-relationships with socioeconomic or environmen-
tal factors, as determinants of adverse health outcomes, need further research; expected
results will help to adapt public policies. Likewise, frailty as a marker of a possibly
reversible vulnerability to adverse outcomes is worth screening in clinical settings in
order to detect patients in need of CGA. Health and social problems identified from
Santos-Eggimann and Sirven Public Health Reviews  (2016) 37:7 Page 11 of 16
this process may benefit from evidence-based interventions that are not specific to the
management of a still obscure frailty syndrome.
In clinical settings, screening for frailty seems particularly appropriate in the absence
of functional difficulty. It may however not be useful in already disabled patients
because they should systematically benefit from periodic CGA. Although frailty screen-
ing is justified—despite a limited predictive accuracy—in prompting geriatric manage-
ment, making bedside rationing decisions on this basis must be rejected because
currently available frailty assessment tools have large false-positive rates.
Continuing research is needed not only to better understand the nature of frailty but
also to improve screening tools and test the effectiveness of interventions. Such investi-
gations should accompany rather than delay all of the necessary efforts to respond to
needs at the population and individual levels.
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